Glycoursodeoxycholic acid regulates bile acids level and alters gut microbiota and glycolipid metabolism to attenuate diabetes DOI Creative Commons

Bingting Chen,

Yu Bai,

Fenglian Tong

и другие.

Gut Microbes, Год журнала: 2023, Номер 15(1)

Опубликована: Март 26, 2023

Accumulating evidence suggests that the bile acid regulates type 2 diabetes mellitus (T2DM) through gut microbiota-host interactions. However, mechanisms underlying such interactions have been unclear. Here, we found glycoursodeoxycholic (GUDCA) positively microbiota by altering metabolism. GUDCA in mice resulted higher taurolithocholic (TLCA) level and Bacteroides vulgatus abundance. Together, these changes activation of adipose G-protein-coupled receptor, GPBAR1 (TGR5) upregulated expression uncoupling protein UCP-1, resulting elevation white tissue thermogenesis. The anti-T2DM effects are linked with regulation composition. This study metabolism, modifying may be value for treatment T2DM.

Язык: Английский

Gut-microbiota-targeted diets modulate human immune status DOI Creative Commons
Hannah C. Wastyk, Gabriela K. Fragiadakis, Dalia Perelman

и другие.

Cell, Год журнала: 2021, Номер 184(16), С. 4137 - 4153.e14

Опубликована: Июль 12, 2021

Язык: Английский

Процитировано

831

Gut-liver axis: Pathophysiological concepts and clinical implications DOI Creative Commons
Herbert Tilg, Timon E. Adolph, Michael Trauner

и другие.

Cell Metabolism, Год журнала: 2022, Номер 34(11), С. 1700 - 1718

Опубликована: Окт. 7, 2022

Язык: Английский

Процитировано

364

Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity DOI
Herbert Tilg, Timon E. Adolph, Michael Dudek

и другие.

Nature Metabolism, Год журнала: 2021, Номер 3(12), С. 1596 - 1607

Опубликована: Дек. 20, 2021

Язык: Английский

Процитировано

303

Brain–gut–microbiota axis in depression: A historical overview and future directions DOI Creative Commons
Lijia Chang, Wei Yan, Kenji Hashimoto

и другие.

Brain Research Bulletin, Год журнала: 2022, Номер 182, С. 44 - 56

Опубликована: Фев. 11, 2022

Depression is the most common mental disorder and a leading cause of disability worldwide. Despite abundant research, precise mechanisms underlying pathophysiology depression remain elusive. Accumulating evidence from preclinical clinical studies suggests that alterations in gut microbiota, microbe-derived short-chain fatty acids, D-amino acids metabolites play key role via brain–gut–microbiota axis, including neural immune systems. Notably, axis might crucial susceptibility versus resilience rodents exposed to stress. Vagotomy reported block depression-like phenotypes after fecal microbiota transplantation "depression-related" microbiome, suggesting vagus nerve influences through axis. In this article, we review recent findings regarding discuss its potential as therapeutic target for depression.

Язык: Английский

Процитировано

246

Major depressive disorder DOI
Wolfgang Marx, Brenda W.J.H. Penninx, Marco Solmi

и другие.

Nature Reviews Disease Primers, Год журнала: 2023, Номер 9(1)

Опубликована: Авг. 24, 2023

Язык: Английский

Процитировано

241

Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course DOI Creative Commons
Xiaoyuan Zhou,

Ryan Baumann,

Xiaohui Gao

и другие.

Cell, Год журнала: 2022, Номер 185(19), С. 3467 - 3486.e16

Опубликована: Сен. 1, 2022

Язык: Английский

Процитировано

191

Microbiome and metabolome features of the cardiometabolic disease spectrum DOI Creative Commons

Sébastien Fromentin,

Sofia K. Forslund, Kanta Chechi

и другие.

Nature Medicine, Год журнала: 2022, Номер 28(2), С. 303 - 314

Опубликована: Фев. 1, 2022

Abstract Previous microbiome and metabolome analyses exploring non-communicable diseases have paid scant attention to major confounders of study outcomes, such as common, pre-morbid co-morbid conditions, or polypharmacy. Here, in the context ischemic heart disease (IHD), we used a design that recapitulates initiation, escalation response treatment over time, mirroring longitudinal would otherwise be difficult perform given protracted nature IHD pathogenesis. We recruited 1,241 middle-aged Europeans, including healthy individuals, individuals with dysmetabolic morbidities (obesity type 2 diabetes) but lacking overt diagnosis at three distinct clinical stages—acute coronary syndrome, chronic failure—and characterized their phenome, gut metagenome serum urine metabolome. found about 75% features distinguish from after adjustment for effects medication lifestyle are present exhibiting dysmetabolism, suggesting alterations might begin long before onset IHD. further categorized signatures related prodromal specific general each its subtypes de-escalation Discriminant analysis based on could better differentiate metabolically matched compared conventional risk markers, pointing pathophysiological relevance these features.

Язык: Английский

Процитировано

175

The Role of Microbiota in Infant Health: From Early Life to Adulthood DOI Creative Commons
Yao Yao, Xiaoyu Cai, Yiqing Ye

и другие.

Frontiers in Immunology, Год журнала: 2021, Номер 12

Опубликована: Окт. 7, 2021

From early life to adulthood, the microbiota play a crucial role in health of infant. The are not only key regulator infant but also associated with long-term health. Pregnancy is golden time for establishment microbiota, which affected by both environmental and genetic factors. Recently, there an explosion studies on human diseases, application disease or relatively limited because many aspects remain controversial, especially about microbiota. Therefore, critical conclusive review necessary understand fully relationship between In this article, we introduce detail from pregnancy main contents article include maternal adverse outcomes, neonatal during perinatal period life, composition gut prediction health, future study directions

Язык: Английский

Процитировано

171

Combinatorial, additive and dose-dependent drug–microbiome associations DOI
Sofia K. Forslund, Rima Chakaroun, Maria Zimmermann‐Kogadeeva

и другие.

Nature, Год журнала: 2021, Номер 600(7889), С. 500 - 505

Опубликована: Дек. 8, 2021

Язык: Английский

Процитировано

167

Advancing human gut microbiota research by considering gut transit time DOI Creative Commons
Nicola Procházková, Gwen Falony, Lars Ove Dragsted

и другие.

Gut, Год журнала: 2022, Номер 72(1), С. 180 - 191

Опубликована: Сен. 28, 2022

Accumulating evidence indicates that gut transit time is a key factor in shaping the microbiota composition and activity, which are linked to human health. Both population-wide small-scale studies have identified as top covariate contributing large interindividual variation faecal composition. Despite this, still rarely being considered field of microbiome. Here, we review latest research describing how why whole segmental times vary substantially between within individuals, variations impact composition, diversity metabolism. Furthermore, discuss mechanisms by may causally affect motility. We argue taking into account intraindividual differences time, can advance our understanding diet–microbiota interactions disease-related microbiome signatures, since these often be confounded transient or persistent alterations time. Altogether, better complex, bidirectional required understand health disease.

Язык: Английский

Процитировано

163